Company Statement: Teva and Cephalon receive European Commission approval for acquisition
MLex Summary: Israeli company Teva announced that it has received conditional merger clearance from the European Commission for its planned acquisition of US biopharmaceutical company Cephalon. Teva has to divest Cephalon's...To view the full article, register now.
Already a subscriber? Click here to view full article